Events

Post-Issuance Compliance Workshop

November.03.2022 - November.04.2022 | Virgin Hotels Nashville and Virtual

JOIN BLX AND ORRICK AT THE POST-ISSUANCE COMPLIANCE WORKSHOP A Comprehensive Overview of Post-Issuance Tax Law and SEC Secondary Market Disclosure for 501(c)(3) Organizations and State and Local Government Issuers Who Utilize Tax-Exempt Financing Virgin Hotels Nashville and Virtual - November 3-4, ...

Events

A Word About Wind’s 2022 Financing Wind North America Conference

November.02.2022 | Convene

Orrick is proud to sponsor A Word About Wind’s 2022 Financing Wind North America Conference, where Blake Winburne will moderate the “Offshore Wind: Is the Momentum now Unstoppable?” panel discussion on opportunities and challenges for the U.S. offshore wind sector and building a robust supply ...

Events

Anti-Money-Laundering | A FELABAN Spanish-Language Webinar

October.28.2022 |

Daniel R. Alonso discussed AMLA 2020 and U.S. access to records held by foreign respondent banks at a FELABAN (Latin American Banking Federation) webinar.

Events

Data Protection Academy: Blockchain and the Data Protection Paradox

October.25.2022 | Webinar

In collaboration with BDO USA, LLP, Daniel Forester and Nicholas Farnsworth will lead “Blockchain and the Data Protection Paradox,” a Data Protection Academy training course.

Events

2022 NAGTRI National Anticorruption Academy

October.24.2022 - October.28.2022 | New York, NY

Daniel R. Alonso moderated a conversation on investigating and prosecuting high-profile cases and the need for maintaining confidentiality, fairness, and an unbiased approach throughout the process.

Events

Are there still opportunities in China and Asia for US biopharmas?

October.19.2022 | Orrick New York

China is the second largest pharmaceutical market in the world, growing to $205bn by 2026. With an increasing focus on innovation and early access, many US biopharmas have found that an anchor in China supports accelerated clinical development and creates incremental value via either through equity ...